Red~One, Don't waste your time responding to Mo..er F...ers on Salzman payroll to lure in fresh meat to this mess of a company......They have no skin in the game and just here to mislead investors.......These scumbags are worst than Salzman.....THE SP MOVEMENT AFTER "THE LATEST GLORIOUS SHAM OF NR" talks volume!
SIX WEEKS DELAY TO CORRECT TYPOS after MANY MANY MONTHS OF DELAY.
Nope wrong again
Claritas Announces Transfer of GVHD Program and Cancellation of Related Debt as Company Focuses on Nitric Oxide Therapeutics
June 1, 2021
SAN FRANCISCO, CA and TORONTO, ON — (June 1, 2021) – Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: KALTF) (the “Company” or “Claritas“) today announced that it has entered into an agreement (the “Debt Forgiveness Agreement”) with the former shareholders of Talent Biotechs Ltd. (the “Talent Shareholders”), under which Claritas will transfer all assets of its program developing cannabidiol for the prevention and treatment of graft versus host disease (the “GVHD Program”) to the Talent Shareholders in exchange for forgiveness of debt and contingent liabilities.